• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP
Click for more information
3.13% 3.3¢

TRYPTAMINE THERAPEUTICS LIMITED - News & Media

Market Cap $35.93M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. It intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The Company is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The Company's pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Tryptamine to plug $6M placement funding into acceleration of IV-infused psilocybin treatment trials

Tryptamine Therapeutics Ltd has confirmed interest from investors in a Placement worth $6M to boost clinical trials of TRP-8803

4 days ago

Tryptamine psilocin treatment ruled safe in IV infusion during early trial

Tryptamine Therapeutics Ltd has been told by a Safety Committee that its IV-infused psilocin therapy is safe for patient use

18 Oct 2024 09:32 (AEDT)

Tryptamine Therapeutics wraps up first-ever IV psilocin injections to establish baseline safety data

Tryptamine Therapeutics (ASX:TYP) has confirmed it's wrapped up its first-ever IV psilocin injections in 11 patients being used to establish baseline dosage data.

26 Aug 2024 10:15 (AEST)

Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first

Tryptamine Therapeutics (ASX:TYP) has finished dosing the first patient with psilocin using an IV drip in a global first.

01 Jul 2024 10:52 (AEST)



(20min delay)
Last
3.3¢ 		Change
0.001(3.13%) 		Mkt cap ! $35.93M
Open High Low Value Volume
3.2¢ 3.4¢ 3.2¢ $186.3K 5.674M

Buyers (Bids)

No. Vol. Price($)
1 8742 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 217109 3
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
Last
3.3¢ 		  Change
0.001 ( 1.85 %)
Open High Low Volume
3.3¢ 3.4¢ 3.2¢ 3213948
Last updated 15.59pm 01/11/2024 ?
TYP (ASX) Chart

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Making money: How many microcaps should be in an investor's portfolio? In this interview Dale Gillham and small cap company director Rod North discuss what to look for in microcap stocks and what place they should have in an investor portfolio.
What each US election outcome would mean for Australian companies & investors We all know that what happens in the US ripples down to impact Australia. Next week’s US presidential elections will be a major catalyst…
Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red? Headline inflation in Australia has fallen to 2.8%, and that officially takes us into the RBA's 2-3% inflation target band. But...
Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too We all know what a year it’s been for gold @ the safe haven yellow metal has, perhaps unsurprisingly, been the net beneficiary of our troubled political times.But what about that other so-called safe haven asset @ Bitcoin? The price of Bitcoin has recently hit a fresh All Time Hig...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.